CategoryAlzheimers Disease

New PET-CT Technique Permits Earlier Detection of Alzheimer’s Disease


Alzheimer’s disease is the most common form of dementia, a term describing the loss of memory and other cognitive functions to the point of interfering with daily life. Alzheimer’s is predominantly a disease of late middle and old age, affecting up to 13% of individuals over the age of 65. The disease is progressive, meaning that the symptoms of memory loss, personality change and confusion...

The Junk Food-Alzheimer’s Connection


As people concerned about our health, readers of this Internet website have learned a great deal about how poor diet affects our health, and puts us at increased risk of contracting diseases. Many of these diseases – diabetes being the most prevalent – are essentially metabolic disorders, caused by our bodies’ inability to properly break down and process the foods that we eat, and convert...

The Best Means of Avoiding Alzheimer’s Is Dance?


That seems to be the gist of a new study published in the New England Journal of Medicine. The research, led by neurologist Dr. Joe Verghese at Albert Einstein College of Medicine, followed elderly subjects over an impressive 21-year period to determine which activities most improved their sharpness of mind, and thus staved off the debilitating effects of Alzheimer’s disease. The...

‘Musical Memory Box’ Helps Alzheimer’s Sufferer


Are our memories of music stored and/or accessed differently in the brain than other memories? That is what is suggested by several research studies and by the creative efforts of a graduate of the University of Brighton School of Design in England. The research – musical memory persists after other memories have gone The heartbreak of Alzheimer’s dementia is that many of the...

A Drug for WHAT May Halt or Reverse Alzheimer’s Disease?


I should state at the outset that the research I’m reporting on was done on mice. Thus, it is preliminary, and no one who is concerned about Alzheimer’s should rush to the pharmacy to stock up on a drug called ustekinumab (marketed as Stelara), even though you would find it there. The authors of the study specifically caution against this, and against making too much of their findings...

Juliette Siegfried, MPH

Juliette Siegfried, MPH

Juliette Siegfried, MPH, has been involved in health communications since 1991. Shortly after obtaining her Master of Public Health degree, she began her career at the National Institutes of Health in Bethesda, Maryland. Juliette now lives in Europe, where she launched ServingMed(.)com, a small medical writing and editing business for health professionals all over the world.

Juliette's resume, facebook: juliette.siegfriedmph, linkedin: juliettes, (+31) 683 673 767